TruTag Technologies

Ownership

Private

Employees

~35

Therapeutic Areas

Other

Stage

Commercial

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Modalities

Device (on-dose authentication)Nanoparticle (nanoporous silica barcodes)

TruTag Technologies General Information

TruTag Technologies has commercialized an on-dose authentication solution using invisible, edible nanoporous silica barcodes to enhance drug and product security. The technology has been recognized by industry awards and adopted in pharmaceutical supply chains for anti-counterfeiting and traceability.

Contact Information

Website

https://trutags.com/

Primary Industry

Non-Drug Biotech

Corporate Office

Emeryville, California
United States

Drug Pipeline

No pipeline data available

For full access to TruTag Technologies's pipeline data

Book a demo

Key Partnerships

EVOTEQ – partnership for pharmaceutical supply chain traceability solutions in healthcare sector

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

TruTag Technologies Funding

No funding data available

Early Stage VC (Series A)	04-Jun-2020	$38M	Completed	Phase 1
Seed Round	12-Feb-2019	$8.5M	Completed	Startup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more

To view TruTag Technologies's complete valuation and funding history, request access »